(19)
(11) EP 3 648 764 A2

(12)

(88) Date of publication A3:
28.03.2019

(43) Date of publication:
13.05.2020 Bulletin 2020/20

(21) Application number: 18828925.0

(22) Date of filing: 03.07.2018
(51) International Patent Classification (IPC): 
A61K 31/4422(2006.01)
A61K 31/4164(2006.01)
A61P 35/00(2006.01)
A61K 31/4172(2006.01)
A61K 31/435(2006.01)
A61K 31/4427(2006.01)
(86) International application number:
PCT/IB2018/054927
(87) International publication number:
WO 2019/008516 (10.01.2019 Gazette 2019/02)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA ME
Designated Validation States:
KH MA MD TN

(30) Priority: 03.07.2017 US 201762528259 P
27.07.2017 US 201762537598 P

(71) Applicant: Menri Group Ltd.
6701101 Tel Aviv (IL)

(72) Inventor:
  • MATZA, Yehuda
    9074848 Mevaseret-Zion (IL)

(74) Representative: Ponti & Partners, S.L.P 
C. de Consell de Cent 322
08007 Barcelona
08007 Barcelona (ES)

   


(54) TREATMENT OF CANCER WITH DIHYDROPYRIDINES